 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Current Price	$88.13
Prev Close	$86.57
Open	$87.00
Dividend Yield	0.00%
50-Day Moving Average	$83.45
Beta	0.80
Avg. Volume	313,999.73
PE Ratio	39.25

52-Week High	$91.39
52-Week Low	$58.23
Market Capitalization	$4.45B
EPS	$2.25
Price to Book	5.44
Revenue Per Employee	$385,187.87
Enterprise Value/EBITDA	18.18

HAE Haemonetics Corp.

About

Feed

Fundamentals

News